Holen Sie sich die Stockscreener-App
6.0258
3.59%
-0.2342
Schlusskurs vom Vortag:
$6.26
Offen:
$6.28
24-Stunden-Volumen:
1.43M
Relative Volume:
0.32
Marktkapitalisierung:
$1.09B
Einnahmen:
$2.51B
Nettoeinkommen (Verlust:
$-171.15M
KGV:
-6.2554
EPS:
-0.9633
Netto-Cashflow:
$122.59M
1W Leistung:
-6.58%
1M Leistung:
-15.36%
6M Leistung:
+13.87%
1J Leistung:
-22.63%
1-Tages-Spanne:
$6.01
$6.29
1-Wochen-Bereich:
$6.02
$6.61
52-Wochen-Spanne:
$4.40
$9.8868
Teladoc Health Inc Stock (TDOC) Company Profile
Firmenname
Teladoc Health Inc
Sektor
Branche
Telefon
(203) 635-2002
Adresse
155 E 44TH STREET, NEW YORK, NY
Compare TDOC vs VEEV, BTSG, TEM, TXG, HQY
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TDOC
Teladoc Health Inc
|
6.025 | 1.14B | 2.51B | -171.15M | 122.59M | -0.9633 |
VEEV
Veeva Systems Inc
|
262.10 | 42.88B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
61.86 | 12.38B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
62.39 | 11.67B | 1.36B | -302.91M | -219.93M | -1.7182 |
TXG
10 X Genomics Inc
|
66.48 | 8.55B | 638.78M | -22.66M | 122.18M | -0.1744 |
HQY
Healthequity Inc
|
93.23 | 7.72B | 1.34B | 230.70M | 440.96M | 2.6695 |
Teladoc Health Inc Stock (TDOC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-10 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2026-02-26 | Hochstufung | BofA Securities | Neutral → Buy |
| 2025-12-09 | Eingeleitet | Barclays | Equal Weight |
| 2025-11-13 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2025-07-25 | Eingeleitet | Mizuho | Neutral |
| 2024-11-15 | Eingeleitet | Goldman | Buy |
| 2024-09-17 | Bestätigt | Jefferies | Hold |
| 2024-02-29 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-02-26 | Eingeleitet | Leerink Partners | Market Perform |
| 2024-01-17 | Herabstufung | DA Davidson | Buy → Neutral |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2023-04-12 | Eingeleitet | Stephens | Equal-Weight |
| 2023-02-23 | Hochstufung | SVB Securities | Market Perform → Outperform |
| 2022-10-24 | Hochstufung | Guggenheim | Sell → Neutral |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2022-09-07 | Eingeleitet | Truist | Hold |
| 2022-08-17 | Herabstufung | Guggenheim | Neutral → Sell |
| 2022-08-12 | Eingeleitet | DA Davidson | Buy |
| 2022-08-02 | Herabstufung | Berenberg | Buy → Hold |
| 2022-08-02 | Herabstufung | Cowen | Outperform → Market Perform |
| 2022-07-28 | Herabstufung | Goldman | Buy → Neutral |
| 2022-07-28 | Herabstufung | Needham | Buy → Hold |
| 2022-07-06 | Bestätigt | BofA Securities | Neutral |
| 2022-05-05 | Herabstufung | Argus | Buy → Hold |
| 2022-04-28 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-04-28 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2022-04-28 | Herabstufung | Guggenheim | Buy → Neutral |
| 2022-04-28 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-04-28 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2022-04-28 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-04-28 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2022-04-07 | Eingeleitet | Guggenheim | Buy |
| 2022-04-01 | Fortgesetzt | Credit Suisse | Outperform |
| 2022-03-03 | Hochstufung | Argus | Hold → Buy |
| 2022-02-23 | Bestätigt | BofA Securities | Neutral |
| 2022-02-23 | Bestätigt | Craig Hallum | Hold |
| 2022-02-23 | Bestätigt | Evercore ISI | In-line |
| 2022-02-23 | Bestätigt | Goldman | Buy |
| 2022-02-23 | Bestätigt | JP Morgan | Overweight |
| 2022-02-23 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2022-02-23 | Bestätigt | Needham | Buy |
| 2022-02-23 | Bestätigt | Oppenheimer | Outperform |
| 2022-02-23 | Bestätigt | Stifel | Hold |
| 2022-02-11 | Eingeleitet | Goldman | Buy |
| 2022-02-08 | Bestätigt | Piper Sandler | Overweight |
| 2021-12-02 | Fortgesetzt | Jefferies | Hold |
| 2021-11-22 | Herabstufung | BTIG Research | Buy → Neutral |
| 2021-10-28 | Bestätigt | Barclays | Equal Weight |
| 2021-10-28 | Bestätigt | BofA Securities | Neutral |
| 2021-10-28 | Bestätigt | Canaccord Genuity | Buy |
| 2021-10-28 | Bestätigt | Citigroup | Buy |
| 2021-10-28 | Bestätigt | Craig Hallum | Hold |
| 2021-10-28 | Bestätigt | Needham | Buy |
| 2021-10-28 | Bestätigt | Oppenheimer | Outperform |
| 2021-10-28 | Bestätigt | Piper Sandler | Overweight |
| 2021-10-28 | Bestätigt | UBS | Neutral |
| 2021-10-19 | Eingeleitet | Wells Fargo | Overweight |
| 2021-08-02 | Herabstufung | Argus | Buy → Hold |
| 2021-07-28 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2021-05-28 | Eingeleitet | Robert W. Baird | Neutral |
| 2021-04-15 | Eingeleitet | Needham | Buy |
| 2021-01-07 | Eingeleitet | BTIG Research | Buy |
| 2020-12-22 | Eingeleitet | Evercore ISI | In-line |
| 2020-12-07 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2020-12-04 | Eingeleitet | Goldman | Neutral |
| 2020-11-13 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2020-09-22 | Eingeleitet | DA Davidson | Buy |
| 2020-09-02 | Hochstufung | Berenberg | Hold → Buy |
| 2020-08-17 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2020-07-14 | Eingeleitet | Citigroup | Buy |
| 2020-07-13 | Eingeleitet | Argus | Buy |
| 2020-07-07 | Eingeleitet | Stephens | Overweight |
| 2020-04-30 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2020-04-13 | Eingeleitet | SVB Leerink | Outperform |
| 2020-03-31 | Herabstufung | Berenberg | Buy → Hold |
| 2020-03-25 | Herabstufung | Craig Hallum | Buy → Hold |
| 2020-03-16 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-03-12 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2020-02-28 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-02-12 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2020-01-10 | Eingeleitet | UBS | Neutral |
| 2020-01-09 | Herabstufung | BofA/Merrill | Buy → Neutral |
Alle ansehen
Teladoc Health Inc Aktie (TDOC) Neueste Nachrichten
Avoiding Lag: Real-Time Signals in (TDOC) Movement - news.stocktradersdaily.com
2 Beaten-Down Stocks to Avoid Right Now - The Globe and Mail
Here's Why Teladoc's Integrated Care Business Deserves More Attention - The Globe and Mail
Teladoc Health | 4: Statement of changes in beneficial ownership of securities-Officer Bliss Kelly - Moomoo
Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08 - GlobeNewswire
Teladoc Health (TDOC) CEO sells 18,327 shares after stock awards vest - Stock Titan
Equity awards vest for Teladoc Health (NYSE: TDOC) accounting chief - Stock Titan
15,311 stock units vest for Teladoc (TDOC) exec as she sells shares for taxes - Stock Titan
Teladoc Health (TDOC) exec sells shares to cover taxes after 14,928 units vest - Stock Titan
RSU vesting prompts Teladoc (TDOC) executive to sell shares for taxes - Stock Titan
Teladoc Health (NYSE: TDOC) president sells 15,251 shares - Stock Titan
Teladoc Health | 144: Notice of proposed sale of securities pursuant to Rule 144 - Moomoo
Teladoc Health (NYSE: TDOC) officer plans sale of 9,812 recently vested shares - Stock Titan
The Escalator: GSK, Teladoc, FINN Partners and more - Medical Marketing and Media
Chutes & Ladders—Teladoc Health taps new CFO; Johns Hopkins Health Plan names interim CEO - Fierce Healthcare
Planned stock sale by Teladoc (NYSE: TDOC) officer covers 7,357 shares - Stock Titan
Teladoc Health (NYSE: TDOC) insider lines up 5,439-share stock sale tied to vested awards - Stock Titan
Teladoc (NYSE: TDOC) exec plans stock sale, including shares to cover taxes on vested stock - Stock Titan
Teladoc (NYSE: TDOC) officer plans $39K stock sale - Stock Titan
Teladoc Health (NYSE: TDOC) holder plans 18,327-share Rule 144 sale - Stock Titan
Teladoc Health (NYSE: TDOC) Names Grasher Michael F as CFO and Records New Insider Status - Kalkine Media
Teladoc Health stock rises on a new CFO and steady July results - AD HOC NEWS
Here's Why Investors Should Stay Neutral on TDOC Stock for Now - TradingView
Teladoc Health CFO Michael F. Grasher Granted 239,616 Restricted Stock Units on September 1, 2026 - Kalkine Media
Teladoc Health Appoints Michael Grasher as New CFO - The Globe and Mail
Insider at Teladoc (TDOC) reports new stock trades - Stock Titan
Teladoc (NYSE: TDOC) CFO Michael Grasher listed as insider with no trades reported - Stock Titan
What Teladoc Health (TDOC)'s New Insurance-Focused CFO Appointment Means For Shareholders - simplywall.st
CCORF Maintains Teladoc Health(TDOC.US) With Buy Rating, Maintains Target Price $10 - Moomoo
Teladoc nabs insurance veteran as new CFO - Healthcare Dive
Teladoc appoints insurance executive Michael Grasher as CFO - Y100 WNCY
Some People Are Leaning On AI For Mental Health Support. Here's Why It’s Not a Substitute For A Licensed Therapist - forbes.com
Teladoc Health names Michael Grasher as chief financial officer By Investing.com - Investing.com South Africa
Teladoc Health names Michael Grasher as chief financial officer - Investing.com
Teladoc Health Appoints Michael Grasher as Chief Financial Officer - globenewswire.com
Teladoc (TDOC) Down 3.3% Since Last Earnings Report: Can It Rebound? - Yahoo Finance
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teladoc Health, Inc.TDOC - PR Newswire
Teladoc Health (TDOC) Director Exit Keeps Fair Value Debate In Focus - Yahoo Finance
Teladoc Health (TDOC) Is Down 6.2% After Cutting 2026 Outlook And BetterHelp StrainsHas The Bull Case Changed? - simplywall.st
Bronstein, Gewirtz & Grossman, LLC (TDOC) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Did Teladoc Health, Inc. Insiders Breach their Fiduciary Duties to Shareholders? - Morningstar
Law firm probes Teladoc Health officers for pos... - Pluang
2026-08-16 | Teladoc Health, Inc. (TDOC) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation | NYSE:TDOC | Press Release - Stockhouse
5 Best Telemedicine and Telehealth Stocks for 2026 and How to Invest - The Motley Fool
TDOC News | TELADOC HEALTH INC (NYSE:TDOC) - ChartMill
Healthcare giants team up for new adolescent behavioral care initiative - AOL.com
Truist Securities Adjusts Price Target on Teladoc Health to $8 From $9, Keeps Hold Rating - marketscreener.com
Teladoc Health (TDOC) Could Be 55% Undervalued On Board Change And 2026 Guidance - Sahm
Teladoc's David B. Snow, Jr. to Retire from Board on Sept 30, 2026 - TradingView
Teladoc Health, Inc. (TDOC) Stock Price, News, Quote & History - Yahoo! Finance Canada
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Teladoc Health, Inc. (TDOC) And Encourages Shareholders to Reach Out - ACCESS Newswire
Finanzdaten der Teladoc Health Inc-Aktie (TDOC)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.02%
0.42%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):